Regulation Mechanism of TFP on TGF-β1/STAT3 Signaling Pathway in Immune-mediated Liver Injury in Mice

被引:0
|
作者
Yuanyu LIAN [1 ]
Jie XU [1 ]
Ya GAO [1 ]
Kefeng ZHANG [1 ]
Riming WEI [1 ]
机构
[1] Guilin Medical University
关键词
Total flavonoids extracted from Polygonum perfoliatum L.(TFP); Bacillus Calmette-Guerin plus lipopolysaccharide(BCG+LPS); Immune-mediated liver injury(IMLI); Transforming growth factor-β1(TGF-β1); Signal transducer and activator of transcription 3(STAT3);
D O I
10.19600/j.cnki.issn2152-3924.2020.04.017
中图分类号
R285.5 [中药实验药理];
学科分类号
1008 ;
摘要
[Objectives] To study the effect of total flavonoids extracted from Polygonum perfoliatum L.(TFP) on immune-mediated liver injury induced by bacillus Calmette-Guerin plus lipopolysaccharide(BCG+LPS) in mice, and to explore its action mechanism. [Methods] 60 Kunming mice were divided into normal group, model group, control group(bifendate) and TFP low, medium and high dose groups according to random number table method, with 10 mice in each group. On the first day of modeling, mice were injected with 0.2 mL of BCG solution(12.5 mg/mL) through the tail vein, and on the eleventh day, 0.2 mL of LPS(37.5 μg/mL) were injected into the tail vein to prepare a mouse model of immune-mediated liver injury; from the first day of modeling, the normal group and the model group were administered intragastrically with the corresponding volume of distilled water, and the bifendate group and the TFP high, medium, and low dose groups were administered intragastrically with the corresponding doses once a day for 11 d. After the last time administration, fasting but giving water for 16 h, took blood from eyes, then collected the liver tissue. The levels of alanine transaminase(ALT) and aspartate transaminase(AST) in serum were detected by biochemical method; transforming growth factor-β1(TGF-β1), intercellular adhesion molecule-1(ICAM-1), interleukin-6(IL-6) and interleukin-1β(IL-1β) expression levels in liver tissue were detected by enzyme-linked immunosorbent assay(ELISA); phosphorylated protein tyrosine kinase JAK-2(p-JAK2), phosphorylated signal transducer and activator of transcription 3(p-STAT3) protein expression levels were detected by Western Blot method; the degree of liver tissue lesions was detected by HE staining. [Results] Compared with the model group, the levels of ALT and AST in the serum of mice in each dose group of TFP(high dose 600 mg/kg, medium dose 400 mg/kg, and low dose 200 mg/kg) were reduced, and the activities of T-SOD and GSH-Px were increased; the content or expression of β1, ICAM-1, IL-6, IL-1β decreased, and the expression of p-JAK2 and p-STAT3 protein decreased; pathological sections showed that the degree of inflammatory necrosis and the degree of lesions in the liver tissues of each dose group of TFP were reduced by varying degrees. [Conclusions] TFP has a protective effect on BCG+LPS-induced immune-mediated liver injury in mice. The mechanism may be related to regulating the phosphorylation level of JAK2 and inhibiting the inflammatory reaction, thereby regulating the TGF-β1/STAT3 signaling pathway and improving the immune-mediated liver injury.
引用
收藏
页码:70 / 74
页数:5
相关论文
共 50 条
  • [21] STAT3 activity is necessary and sufficient for the development of immune-mediated myocarditis in mice and promotes progression to dilated cardiomyopathy
    Camporeale, Annalisa
    Marino, Francesca
    Papageorgiou, Anna
    Carai, Paolo
    Fornero, Sara
    Fletcher, Steven
    Page, Brent D. G.
    Gunning, Patrick
    Forni, Marco
    Chiarle, Roberto
    Morello, Mara
    Jensen, Ole
    Levi, Renzo
    Heymans, Stephane
    Poli, Valeria
    EMBO MOLECULAR MEDICINE, 2013, 5 (04) : 572 - 590
  • [22] Fedratinib Attenuates Bleomycin-Induced Pulmonary Fibrosis via the JAK2/STAT3 and TGF-β1 Signaling Pathway
    Ruan, Hao
    Luan, Jiaoyan
    Gao, Shaoyan
    Li, Shuangling
    Jiang, Qiuyan
    Liu, Rui
    Liang, Qing
    Zhang, Ruiqin
    Zhang, Fangxia
    Li, Xiaohe
    Zhou, Honggang
    Yang, Cheng
    MOLECULES, 2021, 26 (15):
  • [23] Role of the TAK1-NLK-STAT3 pathway in TGF-β-mediated mesoderm induction
    Ohkawara, B
    Shiratake, K
    Hyodo-Miura, J
    Matsuo, R
    Ueno, N
    Matsumoto, K
    Shibuya, H
    GENES & DEVELOPMENT, 2004, 18 (04) : 381 - 386
  • [24] Apamin inhibits renal fibrosis via suppressing TGF-β1 and STAT3 signaling in vivo and in vitro
    Mi-Gyeong Gwon
    Hyun-Jin An
    Hyemin Gu
    Young-Ah Kim
    Sang Mi Han
    Kwan-Kyu Park
    Journal of Molecular Medicine, 2021, 99 : 1265 - 1277
  • [25] Apamin inhibits renal fibrosis via suppressing TGF-β1 and STAT3 signaling in vivo and in vitro
    Gwon, Mi-Gyeong
    An, Hyun-Jin
    Gu, Hyemin
    Kim, Young-Ah
    Han, Sang Mi
    Park, Kwan-Kyu
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2021, 99 (09): : 1265 - 1277
  • [26] Involvement of STAT3 and Ets1 in Snail induction by TGF-β.
    Koizumi, Mai
    Miyazawa, Keiji
    Saitoh, Masao
    CANCER SCIENCE, 2021, 112 : 687 - 687
  • [27] Modulation of STAT-3/EGFR/TGF-α signaling pathway in oral cancer
    Nagpal, JK
    Das, BR
    ORAL ONCOLOGY, 2005, 1 (01) : 147 - 148
  • [28] microRNA mediated interaction of TGF-β and BMP1 signaling pathway in hepatic stellate cells during alcoholic liver injury
    Swendsen, Carl S.
    Glaser, Shannon S.
    Francis, Heather L.
    Han, Yuyan
    McCarra, Jennifer
    McDaniel, Kelly
    Venter, Julie
    White, Mellanie
    Liu, Chang-Gong
    Tsukamoto, Hidekazu
    Alpini, Gianfranco
    Meng, Fanyin
    HEPATOLOGY, 2012, 56 : 291A - 292A
  • [29] The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-β signaling
    Lin, L.
    Amin, R.
    Gallicano, G. I.
    Glasgow, E.
    Jogunoori, W.
    Jessup, J. M.
    Zasloff, M.
    Marshall, J. L.
    Shetty, K.
    Johnson, L.
    Mishra, L.
    He, A. R.
    ONCOGENE, 2009, 28 (07) : 961 - 972
  • [30] The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-β signaling
    L Lin
    R Amin
    G I Gallicano
    E Glasgow
    W Jogunoori
    J M Jessup
    M Zasloff
    J L Marshall
    K Shetty
    L Johnson
    L Mishra
    A R He
    Oncogene, 2009, 28 : 961 - 972